In brief
PCOS, also called PMOS following the 2026 name change, is a hormonal and metabolic condition. It can affect ovulation, symptoms and longer-term health, but it does not mean that everyone has the same problems or needs fertility treatment. Diagnosis brings together a clinical pattern and exclusion of other causes; a scan, AMH result or ovulation strip cannot settle it alone.
Useful care starts with your goal: understanding the condition, managing symptoms, planning ahead or receiving conception support. This guide connects those different questions and explains how assessment, action and review can fit together.
Key takeaways
- PCOS and PMOS refer to the same condition; current sources may use either name.
- A diagnosis needs a pattern, not one isolated test. The adult and adolescent pathways differ.
- A positive LH strip is a signal, not direct confirmation that an egg was released.
- Care includes symptoms, metabolic health and emotional wellbeing, whether or not pregnancy is wanted.
- Fertility support should consider the whole route and use a treatment plan with review points.
What is PCOS, and why are some resources calling it PMOS?
PCOS is the familiar name for a condition involving reproductive hormones and wider metabolic health. In May 2026, the international guideline community introduced polyendocrine metabolic ovarian syndrome, shortened to PMOS. The NHS now uses that name too. They describe the same condition; a change of terminology does not mean that you have acquired a second diagnosis.
The older name can make the condition sound as though it is simply a collection of ovarian cysts. It is broader than that. Symptoms and care needs differ, and an ovarian appearance alone does not tell the whole story. This guide uses PCOS and PMOS together so that information from different appointments, reports and searches remains connected.
You do not need to be trying for pregnancy to deserve an explanation or treatment for symptoms. Your priorities might be understanding your body, managing bleeding or acne, protecting future options, or preparing for conception or fertility treatment. Start with your current question rather than allowing a diagnostic label to choose every next step for you.
Which symptoms are worth discussing?
Possible features include infrequent or unpredictable periods, unwanted facial or body hair, scalp hair thinning and acne. The combination and impact vary. Some people first seek help because of symptoms; others discover a possible pattern during fertility assessment. Neither the absence of acne nor a particular body size settles whether you have the condition.
Symptoms deserve attention in their own right. Explain how bleeding, hair changes, skin concerns, fatigue or mood affect ordinary life. A useful consultation makes room for those concerns instead of treating pregnancy as the only outcome that matters. You can ask for the language, examination arrangements and support that make care accessible to you.
Several conditions can cause overlapping symptoms. PCOS should not become a shortcut that explains every new change. Tell a clinician about rapid progression, a major change from your usual pattern, medicines and any possibility of pregnancy. The next assessment should investigate the particular change rather than automatically repeat a previous label.
How is PCOS diagnosed in adults?
WHO describes diagnosis using at least two of three features after other causes have been excluded: ovulatory or menstrual disturbance, evidence of excess androgens, and polycystic ovarian appearance on ultrasound. Androgens are hormones present in everyone; the question is whether their level or effects fit the clinical pattern.
The international guideline allows AMH to help define the ovarian-appearance component in adults as an alternative to ultrasound. AMH is not a stand-alone PCOS test. Where irregular cycles and androgen excess already establish the relevant pattern, an additional AMH or scan is not necessarily needed just to attach the label. Adult AMH criteria should not be applied to adolescents.
Ask which criteria you meet and which alternative explanations were considered. This makes the reasoning understandable and gives future clinicians something more useful than an unexplained diagnosis on a record. It also separates the diagnosis from decisions about symptoms, metabolic checks and fertility, which still need individual planning.
| Area | What is assessed | What it cannot establish alone |
|---|---|---|
| Ovulation and cycles | Period history and ovulatory function | Irregular bleeding has more than one possible cause |
| Androgen effects | Relevant symptoms and/or appropriately interpreted blood tests | Acne alone does not diagnose the whole condition |
| Ovarian features | Ultrasound, or AMH within the adult guideline algorithm | An ovarian appearance or high AMH is not the entire diagnosis |
Which tests answer which questions?
An assessment may include targeted hormone testing to distinguish PCOS from other explanations, alongside checks relevant to general health. The NHS describes blood tests, blood pressure and cholesterol or diabetes assessment as parts of care. Your clinician should explain which checks are appropriate for your symptoms and history rather than present one universal fertility panel.
Bring a medicine and supplement list, including hormonal contraception or gender-affirming treatment where relevant. Ask whether a medicine affects interpretation and how assessment can be arranged safely. Do not stop prescribed treatment to make a blood test easier to interpret without an agreed plan, including contraception if needed.
Keep the investigation question visible: are we establishing a diagnosis, checking metabolic health, confirming ovulation, or preparing for treatment? A result useful for one question may not answer the others. Our Complete Guide to Fertility Blood Tests explains that distinction in more detail.
How can PCOS affect ovulation?
Ovulation is the release of an egg from a developing follicle. Hormone signalling coordinates that process. With PCOS, ovulation may be infrequent or absent; this can make the opportunity for fertilisation less predictable. That is different from proving that someone can never conceive.
An LH urine test detects a hormonal signal associated with approaching ovulation. ASRM notes that a persistently higher background LH level in PCOS can produce false-positive urinary results. A positive strip does not directly observe an egg being released. If confirmation would change care, the clinician can choose an appropriate assessment rather than ask you to keep buying strips indefinitely.
Cycle information is still useful. Record the first day of bleeding, approximate cycle lengths and what you have observed without turning daily tracking into a requirement. A coherent history helps the clinician decide whether the main question is ovulation, the underlying cause of irregular cycles, or something else. Regular-looking cycles can sometimes coexist with ovulatory dysfunction, so symptoms and context matter.
Does high AMH mean good fertility, or confirm PCOS?
Neither conclusion follows from the number alone. AMH can contribute to the adult diagnostic pathway, but the guideline specifically advises against using it as the sole diagnostic test. A test report needs its method, reference information and clinical context.
Keep three conversations separate: whether PCOS criteria are met, what ovarian reserve testing can tell you, and whether the pathway needed for your reproductive goal is working. A reassuring finding about one part of that pathway should remain reassuring about that part, without being stretched into a guarantee about all the others.
If you already have an AMH result, you do not automatically need another one. Ask what decision it is being used for and whether a repeat would change that decision. The AMH cornerstone explains reserve, egg quality and treatment planning without treating a result as a fertility countdown.
Why does care include metabolic and emotional health?
WHO describes PCOS as a lifelong metabolic condition with possible effects beyond reproduction, including increased risks of type 2 diabetes and other cardiovascular risk factors. Anxiety, depression, body-image concerns and eating difficulties can also affect wellbeing. A risk association does not mean that every individual will develop each problem.
These are separate care needs, not a reason to assume that a person has caused their condition. Agree a practical review plan for relevant health checks and symptoms. Ask who will arrange follow-up, how you will receive the results and what would lead to a change in care.
Emotional support can sit alongside medical care. If tracking, treatment or appearance-related symptoms are taking over your day, say so. You can ask to reduce unnecessary monitoring, discuss the burden of a treatment plan, or seek appropriate psychological support. Being able to cope should not be an eligibility test for being taken seriously.
What if periods are very far apart, or pregnancy is not your goal?
Long gaps between bleeds deserve a conversation about cycle regulation and protection of the uterine lining. WHO notes an association between infrequent periods and endometrial overgrowth; the international guideline places prevention in context while emphasising that the overall chance of endometrial cancer remains low. Do not interpret the diagnosis as a prediction of cancer.
Treatment can be selected for bleeding, skin or hair symptoms and general health when pregnancy is not currently wanted. The NHS describes options including hormonal contraception and other medicines. The right choice depends on symptoms, preferences, medical history and contraindications; fertility treatment is not the default.
Be explicit about your goal and whether avoiding pregnancy matters now. Irregular ovulation is not reliable contraception. You may want symptom control today and a discussion about future pregnancy or preservation later. Those aims can be recorded separately so a future change of plan is easier to navigate.
What can food, movement and support realistically change?
Healthy eating and physical activity can support health even without weight loss. The international guideline finds no single diet composition superior across the outcomes it assessed. A rigid internet PCOS diet should not be presented as the necessary route to being well or becoming pregnant.
Choose changes that fit your health, access, culture, budget and everyday life. A useful goal might concern regular meals, enjoyable movement or support with a specific nutritional difficulty. Where weight management is a personal and clinically relevant goal, it deserves consent, practical help and review rather than blame or a vague instruction.
Ask how progress will be judged. An achievable behaviour, wellbeing measure or clinically relevant result gives the plan a purpose; a promise to cure PCOS or guarantee conception does not. Nutrition or other improvement work can take place alongside appropriate treatment. It should not postpone time-sensitive specialist care.
How should a conception plan be organised?
The first question is which part of the Fertility Dance needs support. If ovulation is infrequent, treatment may focus there. If conception has not occurred despite ovulation, the assessment may need to consider sperm, the fallopian tubes or other relevant factors. PCOS should not make the person with ovaries responsible for every unresolved question.
Work from the actual route: intercourse, donor-sperm insemination, reciprocal IVF or another pathway. Identify who is providing eggs, who is providing sperm and who may carry a pregnancy. That determines which investigations are useful. Do not order the same collection of tests for every participant simply because they are building a family together.
Agree a sequence with review points: what is being addressed first, how response will be checked and when the next decision will be made. Learning or assessment can begin before you have spent a particular number of months trying. Known cycle problems and time-sensitive plans are reasons to discuss options promptly.
| Your situation | Useful question | A practical discussion |
|---|---|---|
| Learning or planning ahead | What does the diagnosis mean for me now? | Symptoms, health checks and future goals |
| Irregular cycles while TTC | Is ovulatory dysfunction the main barrier? | Targeted assessment and possible ovulation treatment |
| Ovulation established, pregnancy unresolved | What else is relevant to this route? | Sperm, tubal or other assessment based on history |
| Donor-sperm or reciprocal treatment | Which role does each person have? | Timing, appropriate checks and clinic coordination |
| Already preparing for IVF | How will response and safety be managed? | A protocol and review with the treating team |
What are the fertility treatment options?
The international guideline recommends letrozole as first-line medication for ovulation induction in people with anovulatory infertility due to PCOS and no other infertility factors. That description matters: it is a recommendation for a defined clinical situation, not a medicine that everyone with the diagnosis needs.
Letrozole requires prescribing and an appropriate treatment plan. NICHD describes medicines, other ovulation treatments and IVF among available approaches. If a first approach does not achieve the intended response, the clinician should explain whether to adjust it, investigate another factor or move to another treatment.
Ask what counts as response, what monitoring is needed, what the treatment risks are and when you will reassess together. Do not copy a dose or schedule from a forum, or treat somebody else's successful cycle as your own prescription. Your treating clinic retains responsibility for fertility medicines and treatment decisions.
What does the letrozole evidence actually show?
A 2014 US multicentre randomised trial compared letrozole with clomiphene in 750 women aged 18–40 with PCOS-related infertility. Participants received up to five treatment cycles. Cumulative live birth occurred in 103 of 374 participants assigned letrozole (27.5%) and 72 of 376 assigned clomiphene (19.1%). The live-birth rate ratio was 1.44, with a 95% confidence interval of 1.10–1.87.
Participants had anovulation plus the study's other PCOS criteria, at least one open fallopian tube, a normal uterine cavity and a male partner meeting the study's sperm-concentration requirement. These are selected treatment-group results, not a monthly pregnancy chance or a forecast for everyone with PCOS. The endpoint was live birth across treatment, not a positive ovulation strip.
When comparing any treatment statistic, keep the denominator, outcome and time period together. A percentage per participant over several cycles cannot be directly compared with a percentage per embryo transfer or per ovulatory cycle. Ask which measure is being quoted before using a number to weigh your options.
What changes for IVF, ICSI or egg freezing?
PCOS does not automatically mean IVF is needed. The international guideline describes escalation when appropriate and specifically addresses reducing ovarian hyperstimulation risk during IVF. If IVF or preservation is relevant, ask the clinic how it will plan stimulation, monitor response and decide the safest next step.
An egg-freezing discussion is a different decision from treating irregular ovulation while TTC. Clarify why preservation is being considered, the role of age and personal plans, what the procedure involves and its limitations. Do not treat the diagnosis or an AMH number alone as a reason to buy a cycle.
If you are already undergoing treatment, use your clinic's instructions rather than general natural-cycle tracking advice. Questions about hormone medicines, retrieval, transfer and safety belong with the team responsible for the protocol. Other health and nutrition support should be coordinated around that care.
How can the plan fit solo, LGBTQ+ and access needs?
PCOS/PMOS can affect anyone with ovaries, including trans and non-binary people. A consultation should use the terms you prefer and focus on anatomy, symptoms, medicines and goals. Discuss whether examinations need adaptation, additional explanation, a support person or a different appointment format.
For solo and same-sex family building, separate the egg-provider and pregnancy-carrier questions. The person with PCOS may be doing one role, both or neither in the immediate plan. The diagnosis should inform the relevant assessment without turning it into a judgement about who ought to carry.
Bring practical constraints into the conversation early: travel for monitoring, work schedules, communication needs, cost and emotional support. A plan that cannot be followed in real life needs adjustment. Ask which visits or tests are essential and how care will be coordinated across services.
What should I leave an appointment understanding?
Write down your main question before the appointment. Bring a brief cycle history, symptoms, medicines, relevant diagnoses and any existing investigations. You do not need a perfect app export or months of home measurements to explain that something concerns you.
Ask for a summary of what is established, what is still uncertain and which action follows. For each proposed test or treatment, ask what decision it could change. Confirm who will review the result, when to expect that review and what should prompt earlier contact.
ProFertility can support education, relevant targeted testing and specialist consultations, with nutrition, emotional support or a coordinated programme where appropriate. Not everyone needs each element. A useful next step should fit the question you actually brought, with a defined review and timely escalation when needed.
Related guidance and support
Related blog articles
Frequently asked questions
Is PMOS a different condition from PCOS?
No. PMOS is the new name introduced by the international guideline community in May 2026 for the condition previously called PCOS. Current resources may use either name.
Can I have PCOS without ovarian cysts?
Yes. The diagnostic pattern can be established without the ovarian-appearance criterion. The name does not mean everyone must have ovarian cysts.
Does high AMH diagnose PCOS?
No. The international guideline allows AMH within the adult diagnostic algorithm, but specifically advises against using it as a stand-alone diagnostic test.
Can I ovulate with PCOS?
Yes. Ovulation patterns vary. If confirming ovulation would change care, a clinician can choose an assessment that fits the cycle and question.
Does a positive ovulation strip prove I released an egg?
No. It detects LH. Background LH can be higher in PCOS, so urinary results may be misleading; the strip does not directly show egg release.
Do I need treatment if I do not want a baby?
Care can address symptoms, cycle regulation and wider health independently of pregnancy plans. Agree priorities based on what matters to you.
Is there one best PCOS diet?
The international guideline does not identify one diet composition as superior across the outcomes assessed. Sustainable, individual support is more useful than a universal restrictive rule.
Does PCOS always require IVF?
No. Depending on the fertility assessment, ovulation treatment or another approach may be appropriate. IVF is one possible pathway, not an automatic consequence of the diagnosis.
Should sperm and tubal factors still be considered?
Yes, when relevant to the conception route and history. PCOS does not establish that ovulation is the only possible factor.
Can I seek advice before trying for pregnancy?
Yes. Learning, symptom management, future planning and assessment of a specific concern are valid reasons to seek support.
Clinical sources
- International evidence-based guideline recommendations (2023), current ASRM version using PMOS terminology; checked 16 October 2026
- Monash University: guideline and current terminology resources; accessed 16 October 2026
- Endocrine Society: PCOS to PMOS name change, 12 May 2026
- WHO: Polycystic ovary syndrome fact sheet, 22 January 2026
- NHS: Polyendocrine metabolic ovarian syndrome; current page accessed 16 October 2026
- ASRM: Fertility evaluation committee opinion (2021), ovulatory testing
- Legro et al.: letrozole versus clomiphene, US randomised trial, NEJM (2014), 750 participants
- NICHD: treatments for PCOS-related infertility; accessed 16 October 2026
Source check: 2026-10-16. This guide is educational and does not replace individual medical advice.